BW
STLN

Boaz Weinstein’s Starling Oncology STLN Stock Holding History

Boaz Weinstein’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-94,264
Closed -$193K – 355
2025
Q2 		$193K Hold
94,264
– – ﹤0.01% 216
2025
Q1 		$107K Hold
94,264
– – ﹤0.01% 161
2024
Q4 		$29.1K Hold
94,264
– – ﹤0.01% 212
2024
Q3 		$30.8K Hold
94,264
– – ﹤0.01% 236
2024
Q2 		$43.4K Hold
94,264
– – ﹤0.01% 248
2024
Q1 		$149K Hold
94,264
– – ﹤0.01% 205
2023
Q4 		$192K Hold
94,264
– – ﹤0.01% 272
2023
Q3 		$132K Sell
94,264
-76,114
-45% -$78.8K ﹤0.01% 315
2023
Q2 		$93.7K Sell
170,378
-4,135
-2% -$2.19K ﹤0.01% 372
2023
Q1 		$118K Hold
174,513
– – ﹤0.01% 459
2022
Q4 		$288K Sell
174,513
-173,546
-50% -$487K ﹤0.01% 562
2022
Q3 		$1.61M Sell
348,059
-19,233
-5% -$113K 0.02% 650
2022
Q2 		$1.86M Sell
367,292
-32,708
-8% -$238K 0.02% 664
2022
Q1 		$2.85M Hold
400,000
– – 0.04% 532
2021
Q4 		$3.73M Buy
400,000
+304,315
+318% +$2.71M 0.06% 431
2021
Q3 		$949K Hold
95,685
– – 0.02% 443
2021
Q2 		$951K Buy
+95,685
New +$963K 0.03% 369
2021
Q1 		– Sell
-17,318
Closed -$187K – 458
2020
Q4 		$187K Sell
17,318
-80,443
-82% -$828K 0.01% 159
2020
Q3 		$1.01M Buy
+97,761
New +$1.02M 0.04% 101

Other funds holding STLN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $413M AUM 109.83% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Boaz Weinstein's STLN Position: Q3 2025 in Review

Boaz Weinstein sold out of Starling Oncology (STLN) in Q3 2025, closing a stake of 94,264 shares — an estimated $193K sold.

Boaz Weinstein first reported a position in STLN in Q3 2020 and held it in 19 quarters. The position peaked at $3.73M in Q4 2021. 108 funds tracked by Wall St. Rank hold STLN as of Q3 2025.

  • Boaz Weinstein reported no remaining Starling Oncology position as of Q3 2025 after selling out during the quarter.
  • Boaz Weinstein sold 94,264 Starling Oncology shares in Q3 2025, an estimated $193K.
  • Boaz Weinstein first reported a position in Starling Oncology in Q3 2020 and held it in 19 quarters.
  • Boaz Weinstein's Starling Oncology position peaked at $3.73M in Q4 2021.
  • 108 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2025.

Based on Saba Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.